相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tocilizumab versus Rituximab in Patients with Moderate to Severe Steroid-resistant Graves' Orbitopathy
Amin Bennedjai et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2022)
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy
F. Nicoli et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)
Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy
Y. P. Hai et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)
Tocilizumab for the Management of Corticosteroid-Resistant Mild to Severe Graves' Ophthalmopathy, a Report of Three Cases
Thomas Maldiney et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2020)
Teprotumumab for the Treatment of Active Thyroid Eye Disease
R. S. Douglas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tocilizumab in glucocorticoid-resistant graves orbitopathy. A case series report of a mexican population
Juan Ceballos-Macias Jose et al.
ANNALES D ENDOCRINOLOGIE (2020)
Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbitopathy: National Multicenter Observational Study of 48 Patients
Lara Sanchez-Bilbao et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Epidemiology, Natural History, Risk Factors, and Prevention of Graves' Orbitopathy
Luigi Bartalena et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy
Terry J. Smith et al.
ENDOCRINE REVIEWS (2019)
Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review
Guillermo Prada-Ramallal et al.
BMC MEDICAL RESEARCH METHODOLOGY (2019)
Subcutaneous Tocilizumab for Thyroid Eye Disease: Simplified Dosing and Delivery
Thomas Copperman et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2019)
Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy
Jonathan C. P. Roos et al.
EYE (2019)
Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy
Diego Strianese et al.
EYE (2019)
Propensity Score Methods: Theory and Practice for Anesthesia Research
Phillip J. Schulte et al.
ANESTHESIA AND ANALGESIA (2018)
Nicotine and autoimmunity: The lotus' flower in tobacco
Joao Pedro Gomes et al.
PHARMACOLOGICAL RESEARCH (2018)
Successful Treatment for Severe Thyroid-associated Ophthalmopathy with Tocilizumab
Carlos A. Canas et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2018)
Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial
Jose Perez-Moreiras et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2018)
Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy
I. Pascual-Camps et al.
ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY (2018)
Teprotumumab for Thyroid-Associated Ophthalmopathy
Terry J. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clinical Response to Tocilizumab in Severe Thyroid Eye Disease
Aileen Sy et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2017)
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement
P. Perros et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Smoke and autoimmunity: The fire behind the disease
Carlo Perricone et al.
AUTOIMMUNITY REVIEWS (2016)
Natural history of diseases: Statistical designs and issues
Nicholas P. Jewell
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy
Luigi Bartalena et al.
EUROPEAN THYROID JOURNAL (2016)
Medical Treatment of Graves' Orbitopathy
M. Salvi et al.
HORMONE AND METABOLIC RESEARCH (2015)
Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
Marius N. Stan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study
Mario Salvi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Recurrent Thyroid Eye Disease
Payal Patel et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2015)
Increased TRAb and/or Low Anti-TPO Titers at Diagnosis of Graves' Disease are Associated with an Increased Risk of Developing Ophthalmopathy after Onset
M. Lantz et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2014)
Treatment of Active Corticosteroid-Resistant Graves' Orbitopathy
Jose Vicente Perez-Moreiras et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
Spontaneous Improvement of Untreated Mild Graves' Ophthalmopathy: Rundle's Curve Revisited
Francesca Menconi et al.
THYROID (2014)
Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center
M. L. Tanda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
A Stimulatory Thyrotropin Receptor Antibody (M22) and Thyrotropin Increase Interleukin-6 Expression and Secretion in Graves' Orbital Preadipocyte Fibroblasts
Seema Kumar et al.
THYROID (2010)
Novel immunomodulating agents for graves orbitopathy
Luigi Bartalena et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2008)
Thyrotropin receptor autoantibodies are independent risk factors for graves' ophthalmopathy and help to predict severity and outcome of the disease
Anja K. Eckstein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Longitudinal correlation of thyroid-stimulating immunoglobulin with clinical activity of disease in thyroid-associated orbitopathy
LR Dragan et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2006)
Randomized, single blind trial of intravenous versus oral steroid monotherapy in graves' orbitopathy
GJ Kahaly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Late reactivation of thyroid orbitopathy
D Selva et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2004)
Impact of smoking on the response to treatment of thyroid associated ophthalmopathy
A Eckstein et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2003)
Smoking and thyroid disorders - a meta-analysis
P Vestergaard
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy
SC Jyonouchi et al.
THYROID (2001)
Effects of L-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study
D Glinoer et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)
Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy
MN Gerding et al.
CLINICAL ENDOCRINOLOGY (2000)
分享论文
